To fight against infectious
diseases and cancers, Institut Mérieux imagines and develops new approaches in the fields of diagnostics, immunotherapy, food safety and nutrition.
Its three bio-industrial companies: bioMérieux, Transgene and Mérieux NutriSciences, working closely with its entities devoted to innovation, such as ABL Inc. and Mérieux Equity Partners, have enabled major advances in medicine and public health.
